ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹64 Cr | ₹54 Cr | ₹28 Cr | ₹25 Cr | ₹20 Cr |
What is the latest Contingent Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹64 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹28 Cr |
| Mar2022 | ₹25 Cr |
| Mar2021 | ₹20 Cr |
How is Contingent Liabilities of ERIS LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹64 Cr | 19.17 | |
| Mar2024 | ₹54 Cr | 90.05 | |
| Mar2023 | ₹28 Cr | 15.82 | |
| Mar2022 | ₹25 Cr | 25.02 | |
| Mar2021 | ₹20 Cr | - | |
Compare Contingent Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,255.0 Cr | -0.7% | -4.3% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -0.7% |
-4.3% |
-25.9% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses